Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
about
Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-AnalysisDiabetic cardiomyopathy: pathophysiology and clinical featuresDiabetic cardiomyopathy: where we are and where we are going.Nonalcoholic fatty liver disease and the heart in children and adolescents.Links between ectopic fat and vascular disease in humansPrognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetesMR proton spectroscopy for myocardial lipid deposition quantification: a quantitative comparison between 1.5T and 3T.Exercise-induced modulation of cardiac lipid content in healthy lean young men.Effects of short-term nutritional interventions on right ventricular function in healthy men.Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus.Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes.Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 DiabetesPericardial- Rather than Intramyocardial Fat Is Independently Associated with Left Ventricular Systolic Heart Function in Metabolically Healthy Humans.Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.Obesity and pulmonary hypertension: a review of pathophysiologic mechanisms.Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 DiabetesNonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver diseaseRole of cardiac MRI in diabetes.Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot studyFatty acid imaging of the heart.Recent advances in metabolic imaging.Management of fatty liver disease with the metabolic syndrome.Intracellular lipid accumulation and shift during diabetes progression.MRS: a noninvasive window into cardiac metabolism.Imaging of myocardial fatty acid oxidation.Oxidized eicosapentaenoic acids more potently reduce LXRα-induced cellular triacylglycerol via suppression of SREBP-1c, PGC-1β and GPA than its intact form.Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot StudyThe loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis.Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases.Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease.MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review.Decreased ATP production and myocardial contractile reserve in metabolic heart disease.Left ventricular diastolic function in type 2 diabetes mellitus is associated with myocardial triglyceride content but not with impaired myocardial perfusion reserve.Time-dependent cellular response in the liver and heart in a dietary-induced obese mouse model: the potential role of ER stress and autophagy.New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
P2860
Q26798155-9B69D5EE-1471-4D17-BFFB-277FE0510BFFQ30457504-92934124-32C5-487E-A135-92B054517557Q33690717-08C7068F-70F0-416D-B5BE-2A74FCFCDC4BQ33958722-A4084CAC-9B2F-40BF-8E30-872FFA83ACDDQ34076155-8D407EC0-744F-434C-9E28-C5977C5C5D06Q34205386-C7F489EF-2096-4A2E-9DCF-53DE155AAE97Q34349173-7B2AF4C2-7CC2-4C6C-8566-02AA2AF61C0FQ34548132-1FF90538-C080-4B1F-90EC-1D29FC2562DCQ35006342-D66730BD-635F-4237-8637-8988CF94F5DBQ35088712-7DCB30B2-2ADF-4315-B992-E0A208136970Q35688259-154C5584-0E94-4247-99D4-89CBE52C8431Q35740071-D018BDC7-3F4D-48FB-B5C8-E5975812E144Q35953956-E9B79488-E656-433E-BC20-2ADC0890BE87Q35995660-B4952589-12B1-4BE2-82F3-367FEC946980Q36228769-50B87845-BA05-42EF-B922-A3EE4E5245D4Q37048666-0BD6E1BB-1AF8-445D-9003-FB24211EEA70Q37375539-27FEAAE3-2F26-46B1-8181-B6AF1B0827D9Q37596189-20CDFD45-A861-4D81-A8FA-81EBC31387C1Q37662894-6D70EA70-B4EA-4732-848B-D9F355234C2DQ37679243-DC8DB2A4-50BD-4691-873B-0E1EC7C65AB7Q37829379-9C7FD0C2-03A8-4CC6-AF6E-16DFA7993699Q38156683-FE12CB75-7286-40FC-900F-B6194524BE14Q38199130-64F59435-5FAE-4A8C-8C9E-C6BC2EF714FAQ38232287-053C71AA-A67C-4D8D-BC3D-C27461652781Q38502630-C655E65A-DDB6-4AAF-9CD2-2DD454DF816EQ38753602-217F846E-0D98-45AD-87FD-DC4DC0A140E2Q39151146-4605AB47-89AA-460A-8506-A0D72D02C37BQ41259429-80E942C5-AE15-4471-8A25-2AABE4CBCC8EQ42374213-22CD2E7C-6E67-45E3-AC16-FADB217E2993Q47156332-A8AD49FE-889B-4459-BBF2-4F766879EAFEQ47739163-4AA4EDA3-BA04-4D70-B4A2-B8E9F3EC5C0CQ48030343-8143910E-9D12-4E46-ABE9-DCD8C96D6ED5Q50026688-AF8ADB4E-299F-4313-8E18-A0636E2F0A71Q50152159-8F13A2D6-897F-4D50-BB1E-11F630D3C78BQ51365596-F0F5E738-233D-4E85-ABEB-0511E802A733Q53388015-631749D3-7FFE-4E3E-855D-C9D580249C36Q57114860-9BD7BA33-3CB9-4CFB-9C49-DF97DB835257
P2860
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
@ast
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
@en
type
label
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
@ast
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
@en
prefLabel
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
@ast
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
@en
P2093
P50
P1476
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
@en
P2093
Albert de Roos
Hildo J Lamb
Hugo W de Jong
Jacqueline T Jonker
Johannes A Romijn
Johannes W A Smit
Jos W Twisk
Luuk J Rijzewijk
Mark Lubberink
Michaela Diamant
P304
P356
10.1016/J.JACC.2010.02.049
P407
P577
2010-07-01T00:00:00Z